SYMPHONX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SYMPHONX Trademark

Serial Number: 79302302 • Registration: 6749084

SYMPHONX is a trademark filed by FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED on July 9, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (16 trademarks)

BELASIS AVENUE
BILLINGHAM TS23 1LH , GB

Entity Type: 03

Trademark Details

Filing Date

July 9, 2020

Registration Date

June 7, 2022

Published for Opposition

March 22, 2022

Goods & Services

Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to the order and specification of others; Manufacture of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others

Fluid processing system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for bioprocessing and pharmaceutical research, comprised primarily of chromatography apparatus for laboratory use, laboratory filters, and fluid handling devices used for bioprocessing applications and component parts and fittings; Liquid chromatography apparatus for laboratory use; Ion exchange chromatography apparatus for the treatment of fluids for laboratory use; Ultrafiltration apparatus for laboratory or scientific research use, namely, ultrafiltration laboratory filters and laboratory ultrafiltration filter membranes as part of scientific apparatus; Diafiltration apparatus for laboratory or scientific research use, namely, laboratory diafiltration filters; Scientific, laboratory, and measuring apparatus and instruments for diluting or concentrating biological products for laboratory or scientific research use, namely, tangential flow filtration devices for preparation of biological samples for use in the biopharmaceutical industry; Laboratory filters in the nature of viral filtration apparatus for removal of viruses from solutions for laboratory or scientific research use; Membrane filtration apparatus in the nature of membrane laboratory filters for use in laboratory equipment in the biopharmaceutical industry for treating biological fluids and solutions; Chromatography apparatus and component parts thereof for laboratory or scientific research use; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electronic sensors specially adapted for use with all of the aforementioned goods; Computer software for control of the aforesaid goods, namely, downloadable and recorded software for operating a fluid processing apparatus for laboratory or scientific research use comprising chromatography, membrane filtration, tangential flow filtration, viral filtration, ultrafiltration, diafiltration, viral filtration, viral inactivation, in-line conditioning, and buffer management components and systems; Computer software for management of biological product purification processes, namely, downloadable and recorded software for managing the purification of cells, viruses, and biomolecules in the nature of nucleic acids and proteins

Fluid processing system apparatus and system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for the pharmaceutical and biomanufacturing industries, namely, chromatography apparatus for industrial use and apparatus and instruments for use in the purification, conditioning, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Liquid chromatography apparatus for industrial purposes; Ion exchange apparatus for the treatment of fluids for industrial purposes; Ultrafiltration apparatus for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Diafiltration apparatus, namely, aqueous solution filtering systems and components and biological fluid filtering systems and components for industrial purposes being apparatus and instruments for use in the purification, separation and sterilization of liquids used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Apparatus for diluting or concentrating biological products for industrial purposes, namely, tangential flow filtration apparatus being apparatus for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Viral filtration apparatus for removal of viruses from solutions for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Virus inactivation and disinfection apparatus for the treatment of biological products in the field of biomanufacturing and pharmaceuticals, all for industrial purposes in the nature of apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Membrane filtration apparatus for industrial purposes in the nature of membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; Chromatography apparatus for industrial purposes and component parts thereof; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electric sensors, specially adapted for use with the aforementioned

Scientific research, industrial biomedical research and technical product research and development services in the field of biomanufacturing, bioprocessing and pharmaceuticals related to biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Process development services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including nucleic acids and proteins, namely, biomedical and pharmaceutical research; Industrial design services related to the manufacture and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Provision of facilities for scientific, industrial and technical research and development in the field of biomanufacturing, bioprocessing and pharmaceuticals, namely, scientific laboratory services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 16, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 19, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 19, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 7, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Mar 27, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 22, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 2, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 2, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 14, 2022 XAEC
ASSIGNED TO LIE
Feb 13, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2022 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 23, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 23, 2021 GNFR
FINAL REFUSAL WRITTEN
Aug 23, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 1, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 20, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
ASSIGNED TO EXAMINER
Jan 15, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 14, 2021 REPR